-
Mashup Score: 6IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s - 12 hour(s) ago
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory bowel disease, Lilly reported. Previously approved for ulcerative colitis in October 2023, Omvoh (mirikizumab-mrkz) enters an increasingly crowded IBD drug market following the approval of rival
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 1Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment - 16 hour(s) ago
Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data. “Prucalopride (1 or 2 mg once daily) has been demonstrated to improve the number of complete spontaneous bowel movements in patients with CIC over a 12-week treatment period as
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
According to data 📈 from @TAGastroenterol, #prucalopride 💊 was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic #constipation, regardless of 👉age, 👉BMI 👉renal function. 🔽 https://t.co/JC5Cxssy4A
-
-
Mashup Score: 0Colonoscopy rescreening could be extended for those with negative results, low CRC risk - 2 day(s) ago
Individuals with negative colonoscopy screening results had lower long-term risk for colorectal cancer and related mortality, with researchers suggesting the recommended 10-year rescreening interval may be extended for this population. “Among average-risk individuals undergoing colonoscopy screening, most have negative examination findings and are free of any neoplasia,” Markus Dines
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
According to @JAMAOnc: Individuals with negative #colonoscopy screening results had lower 📉 long-term risk for #colorectalcancer and related mortality; the recommended 🔟-year rescreening interval may be extended for this population. Learn more 🔽🔽 https://t.co/hT8S0PEuHD
-
-
Mashup Score: 31
More women than ever have joined gastroenterology in the past 20 years — a staggering 219% increase according to the Association of American Medical Colleges — yet they continue to make up only 21% of active physicians in the specialty.While the steady expansion of women physicians is evident in the field of gastroenterology and medicine overall, data have shown that marked
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
‘Having women 👩🏾👩🏽👩🏼👩🏻 at the top’ drives structural change, advances #genderequity in #GI In @GoHealio’s latest cover story 🗞️, champions of gender equity ⭐️ @AmyOxentenkoMD ⭐️ @rina_sanghavi ⭐️ Nancy D. Spector, MD (@ELAMProgram) weighed in ⚖️ ⬇️ https://t.co/FTCUnqGrWg
-
-
Mashup Score: 1Prucalopride still effective in CIC despite older age, unhealthy BMI or renal impairment - 3 day(s) ago
Prucalopride was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic constipation, regardless of age, BMI or renal function, according to data. “Prucalopride (1 or 2 mg once daily) has been demonstrated to improve the number of complete spontaneous bowel movements in patients with CIC over a 12-week treatment period as
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
According to data 📈 from @TAGastroenterol, #prucalopride 💊 was safe and effective in increasing the frequency of complete spontaneous bowel movements in patients with chronic idiopathic #constipation, regardless of 👉age, 👉BMI 👉renal function. 🔽 https://t.co/JC5Cxssy4A
-
-
Mashup Score: 20
This month’s Healio Exclusive highlights an essential dialogue on gender disparities in medicine, particularly in gastroenterology, and the persistent barriers women face in achieving leadership roles.Despite significant growth in the number of women in the field, the data remain sobering: Women comprise just 21% of practicing gastroenterologists, with far fewer in leadership positions. In
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
In the accompanying expert editorial for this month’s @GoHealio #GI exclusive 📰, @IBD_Afzali discussed the pursuit of gender equity: ‘We must move together’ with a growth mindset Check it out at the 🔗 below ⬇️ https://t.co/tDImRBTuu6
-
-
Mashup Score: 30
More women than ever have joined gastroenterology in the past 20 years — a staggering 219% increase according to the Association of American Medical Colleges — yet they continue to make up only 21% of active physicians in the specialty.While the steady expansion of women physicians is evident in the field of gastroenterology and medicine overall, data have shown that marked
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
‘Having women 👩🏾👩🏽👩🏼👩🏻 at the top’ drives structural change, advances #genderequity in #GI In @GoHealio’s latest cover story 🗞️, champions of gender equity ⭐️ @AmyOxentenkoMD ⭐️ @rina_sanghavi ⭐️ Nancy D. Spector, MD (@ELAMProgram) weighed in ⚖️ ⬇️ https://t.co/FTCUnqGrWg
-
-
Mashup Score: 0Q&A: Predictive model using EHR data finds ‘good candidates’ for gastric cancer screening - 5 day(s) ago
A new electronic health record-based model accurately predicted risk for gastric cancer using demographic, behavioral and clinical data and may be leveraged to increase screening in at-risk populations. “We were particularly compelled to look at gastric cancer because it seems tailor made for screening,” Michelle Kang Kim, MD, PhD, chair of the department of gastroenterology,
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨NEW🚨 from @ClevelandClinic: An #electronichealthrecord-based model accurately predicted risk for #gastriccancer and may be leveraged to increase screening in at-risk populations. @MichelleKimMD weighed in ⚖ at the 🔗 below 🔽 https://t.co/Fn5AOYSRHM
-
-
Mashup Score: 2
Endoscopic sleeve gastroplasty with lifestyle intervention was more effective than lifestyle changes alone in achieving weight loss and histological improvement in patients with metabolic dysfunction-associated steatohepatitis and obesity. “Endoscopic bariatric and metabolic therapies are safe and effective for the treatment of obesity and associated metabolic conditions, avoiding
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
Endoscopic sleeve #gastroplasty ➕ lifestyle intervention was more effective than: 👉 lifestyle changes alone in achieving #weightloss and histological improvement in patients with #MASH and #obesity. Check out more from @AGA_CGH at the 🔗 below 🔽 https://t.co/qF40IJZsGX
-
-
Mashup Score: 0Cour Pharmaceuticals snags orphan drug designation for CNP-104 for the treatment of PBC - 6 day(s) ago
The FDA has granted Cour Pharmaceuticals orphan drug designation for CNP-104, a biodegradable nanoparticle in development for the treatment of primary biliary cholangitis, the company announced in a press release. According to Cour, CNP-104 initiates tolerance to pathogenic activated pyruvate dehydrogenase complex-E2 T-cells that “drive inflammation in bile ducts, leading to improvement in
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨BREAKING NEWS🚨 The @US_FDA has granted @CourPharma orphan drug designation 💊 for CNP-104, a biodegradable nanoparticle in development for the treatment of #primarybiliarycholangitis. Learn more at the 🔗 below 🔽 https://t.co/Tk4jEucX3j
-
🚨BREAKING NEWS🚨 @US_FDA has approved @EliLillyandCo's #Omvoh 💊 for the treatment of moderately to severely active #Crohns disease, making it the 2️⃣nd interleukin-23p19 specific inhibitor approved for both major types of #IBD. Learn more 🔽🔽 https://t.co/GaS461rOlD